Med Lett Drugs Ther. 2006;48(1241-1242):65-6.
A recombinant quadrivalent human-papillomavirus-like particle vaccine, Gardasil (Merck), has been approved by the FDA for use in girls and women 9-26 years old to prevent diseases associated with infection with human papillomavirus (HPV) types 6, 11, 16, and 18, including genital warts, precancerous cervical, vaginal or vulvar lesions, and cervical cancer.
一种重组四价人乳头瘤病毒样颗粒疫苗——佳达修（默克公司生产）已获美国食品药品监督管理局批准，用于9至26岁的女性，以预防由6型、11型、16型和18型人乳头瘤病毒（HPV）感染引发的疾病，包括尖锐湿疣、宫颈癌前病变、阴道或外阴的癌前病变以及宫颈癌。
